December 09, 2025 07:00 ET | Source: TransAlta Corporation CALGARY, Alberta, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Highlights TransAlta to…
Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus chemotherapy as 1st-line treatment…
The strategic alliance aims to elevate S.Pellegrino's premium lifestyle positioning, expand engagement with younger audiences and enhance its global brand…
Bilbao, 1 December — Virtualware (EPA: ALVIR), a pioneer in 3D-driven enterprise software, will strengthen its Board of Directors with…
The partnership will enable Bisleri to meet 48% of its electricity needs through renewable energy, while offsetting close to 2,700…
New York, NY, Nov. 25, 2025 (GLOBE NEWSWIRE) -- PhoneX Holdings, Inc. (“PhoneX” or the “Company”) (OTC Pink: PXHI) today…
HONG KONG, Nov. 17, 2025 /PRNewswire/ -- CoinW, a leading global crypto asset trading platform, has officially concluded its 8th-anniversary…
London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs…
Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response…
24-month Phase I follow-up data show positive outcomes are maintained High levels of investigator and patient satisfaction, excellent safety profileOngoing registrational…